What is NDC 51662-1399?

51662-1399 is the product NDC for Bupivacaine Hci And Epinephrine, Bupivacaine hydrochloride 5 mg/mL; Epinephrine bitartrate .005 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 3 package NDCs, shown above in 10- and 11-digit form.

What is the active ingredient?

Bupivacaine hydrochloride, Epinephrine bitartrate.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bupivacaine Hci And Epinephrine?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bupivacaine Hci And Epinephrine NDC 51662-1399

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1399Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1399Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
51662-1399-1	5166213990151662139901	50 mL in 1 VIAL, MULTI-DOSE (51662-1399-1)Marketed from Dec 9, 2019
51662-1399-2	5166213990251662139902	1 VIAL, MULTI-DOSE in 1 POUCH (51662-1399-2) / 50 mL in 1 VIAL, MULTI-DOSEMarketed from Jan 26, 2021
51662-1399-3	5166213990351662139903	25 POUCH in 1 CASE (51662-1399-3) / 1 VIAL, MULTI-DOSE in 1 POUCH / 50 mL in 1 VIAL, MULTI-DOSEMarketed from Jan 26, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bupivacaine Hci And Epinephrine
Generic name (nonproprietary): bupivacaine hci and epinephrine
Active ingredients: Bupivacaine hydrochloride — 5 mg/mLEpinephrine bitartrate — .005 mg/mL
Dosage form: Injection, Solution
Route: Perineural
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070968
Marketing start: Dec 9, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Agonists (Mechanism)Amides (Chemical structure)Catecholamines (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1399_10328ddf-6e3b-c9e0-e063-6294a90a52edSPL ID 10328ddf-6e3b-c9e0-e063-6294a90a52edSPL set ID 99516811-56e2-9c8a-e053-2a95a90ac9cbUNII 7TQO7W3VT8, 30Q7KI53AKUPC 0363323463014
Pharmacologic class: Amide Local Anesthetic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451662139901 followed by a unit qualifier and the quantity

Package 51662-1399-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 30, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE Sensorcaine (bupivacaine HCl) is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see WARNINGS ). Experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of the 0.75% concentration of bupivacaine HCl in these patients. Sensorcaine is not recommended for intravenous regional anesthesia (Bier Block) (see WARNINGS ). The routes of administration and indicated Sensorcaine concentrations are: (See DOSAGE …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1399

What is NDC 51662-1399?: 51662-1399 is the product NDC for Bupivacaine Hci And Epinephrine, Bupivacaine hydrochloride 5 mg/mL; Epinephrine bitartrate .005 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bupivacaine Hci And Epinephrine.
What is the active ingredient?: Bupivacaine hydrochloride, Epinephrine bitartrate.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bupivacaine Hci And Epinephrine?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 070968

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070968
Product	Strength	Form · route	Labeler	Product NDC
Sensorcainebupivacaine hydrochloride and epinephrine bitartrate	Bupivacaine hydrochloride 5 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionPerineural	Fresenius Kabi USA, LLC	63323-463
Sensorcainebupivacaine hydrochloride and epinephrine bitartrate	Bupivacaine hydrochloride 5 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionPerineural	Sportpharm LLC	85766-255